Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $92.4600 (0.22%) ($91.0300 - $94.7400) on Fri. Jun. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.13% (three month average) | RSI | 52 | Latest Price | $92.4600(0.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(51%) SPLV(40%) VYM(37%) DIA(36%) IVE(35%) | Factors Impacting ABBV price | ABBV will decline at least -1.565% in a week (0% probabilities). VIXM(-26%) UUP(-10%) VXX(-7%) TLT(-4%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.565% (StdDev 3.13%) | Hourly BBV | -1 () | Intraday Trend | -1.4% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $94.48(-2.14%) | 10 Day Moving Average | $93.26(-0.86%) | 20 Day Moving Average | $92.32(0.15%) | To recent high | -4.6% | To recent low | 43.3% | Market Cap | $163.126b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |